Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 6, 2026 · most recent call
VTRS’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Viatris’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: VTRS daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
On October 8, 2026, Viatris entered into a merger agreement with Pacira BioSciences. A Viatris subsidiary will commence a tender offer for all outstanding Pacira shares at $36.50 per share in cash, open for 10 business days subject to extension, followed by a merger under Section 251(h) of the Delaware General Corporation Law with no stockholder vote required. The offer is conditioned on, among other things, tenders of more than 50% of Pacira's shares.
What each event means for VTRS’s sentiment score is part of Tellvest Pro.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $3.53B | -8.1% | $-0.43 | +32.8% | 34.4% | -5.1% | -14.6% | $329M |
| FY2025 Q1 | $3.25B | -11.2% | $-2.55 | -2807.0% | 35.7% | -88.6% | -93.5% | $459M |
| FY2025 Q2 | $3.58B | -5.6% | $-0.00 | +98.6% | 37.2% | 6.5% | -0.1% | $166M |
| FY2025 Q3 | $3.76B | +0.2% | $-0.11 | -239.2% | 36.8% | 6.7% | -3.4% | $645M |
| FY2025 Q4 | $3.70B | +5.0% | $-0.30 | +30.2% | 30.6% | -7.2% | -9.2% | $551M |
| FY2026 Q1 | $3.52B | +8.1% | $0.15 | +105.9% | 32.9% | -2.3% | 5.0% | $348M |
| FY2026 Q2Selected | $3.76B | +4.9% | $-0.10 | — | 38.8% | 0.2% | -3.2% | $329M |
Management-stated figures from VTRS’s newest call are part of Tellvest Pro.